Allianz Global Investors Fund - Allianz Global Equity Unconstrained AT EURRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 22.0 | 1.7 | |
+/-Cat | - | - | - | 6.0 | -4.3 | |
+/-B’mrk | - | - | - | -0.3 | -5.3 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 16/05/2024 | EUR 119.11 | |
Day Change | 0.75% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | LU2387748960 | |
Fund Size (Mil) 03/01/2024 | EUR 472.55 | |
Share Class Size (Mil) 16/05/2024 | EUR 67.35 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 16/02/2024 | 2.10% |
Investment Objective: Allianz Global Investors Fund - Allianz Global Equity Unconstrained AT EUR |
Long-term capital growth by investing in global equity markets to achieve a concentrated equity portfolio with a focus on stock selection. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Tobias Kohls 01/02/2021 | ||
Christian Schneider 19/12/2008 | ||
Inception Date 22/02/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR EUR | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Global Equity Unconstrained AT EUR | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Corpay Inc | Technology | 4.58 |
Thermo Fisher Scientific Inc | Healthcare | 4.38 |
Assa Abloy AB Class B | Industrials | 4.14 |
Roper Technologies Inc | Technology | 4.14 |
Visa Inc Class A | Financial Services | 4.11 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Global Equity Unconstrained AT EUR |